Latest Exhaled nitric oxide Stories
Researchers said on Tuesday that a new type of asthma drug could be a potential game changer for patients with moderate to severe disease. The injectable drug, known as dupilumad, slashed asthmatic episodes by 87 percent in a mid-stage trial of 104-patients.
Exploring the latest innovations in healthcare. SOLNA, Sweden (PRWEB) May 06, 2013 Aerocrine AB announced today that their NIOX MINO® device will
Board certified pulmonologist discusses the role of exhaled nitric oxide (eNO) testing in asthma diagnosis and management.
Among adults with asthma controlled with low-dose inhaled corticosteroid therapy, the time to treatment failure was not significantly different among patients who received corticosteroid dose adjustment based on physician assessment, a biomarker, or symptom occurrence.
Higher mortality rates among older adult asthma patients compared to their younger counterparts may be due, at least in part, to an increase in airway inflammation.
Where a child lives can greatly affect his or her risk for asthma.
It is well known that smoking leads to a reduction in levels of fractional exhaled nitric oxide (FeNO), which is a marker for airway inflammation.
By studying mice exposed to tobacco smoke for a period of months, researchers have new insight into how emphysema and chronic obstructive pulmonary disease (COPD) develops.
The American Thoracic Society has issued the first-ever guidelines on the use of fractional exhaled nitric oxide (FENO) that address when to use FENO and how to interpret FENO levels in different clinical settings.
Results from C91 "Late-Breaking Clinical Trials" on Tuesday afternoon, May 17, will bring new light to clinical problems and potential treatments.
- totally perplexed and mixed up.